Cargando…
Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection
Cytomegalovirus (CMV), a member of the Herpesviridae family, is frequent among hematopoietic cell transplant (HCT) and solid organ transplant (SOT) recipients in absence of antiviral prophylaxis, and is a major cause of morbidity and mortality in these vulnerable populations. Antivirals such gancicl...
Autor principal: | Ouellette, Christopher P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694397/ https://www.ncbi.nlm.nih.gov/pubmed/36366468 http://dx.doi.org/10.3390/v14112370 |
Ejemplares similares
-
Immune Prophylaxis and Therapy for Human Cytomegalovirus Infection
por: Struble, Evi B., et al.
Publicado: (2021) -
Immunotherapy with adoptive cytomegalovirus‐specific T cells transfer: Summarizing latest gene engineering techniques
por: Mehdizadeh, Mahshid, et al.
Publicado: (2021) -
Cytomegalovirus-Specific Immunotherapy for Glioblastoma Treatments
por: Ahn, Jaehyun, et al.
Publicado: (2022) -
Letermovir for cytomegalovirus prophylaxis
Publicado: (2019) -
A Plea for the Adoption of Oral Prophylaxis
por: Rogers, Grace P.
Publicado: (1906)